Yan Zong
- Topics
- RNA Interference and Gene Delivery (4 papers)Cancer-related molecular mechanisms research (3 papers)Cancer, Hypoxia, and Metabolism (3 papers)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Yan Zong
25 papers receiving 527 citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Molecular Biology 353
- Immunology 111
- Oncology 89
- Cancer Research 83
- Biomedical Engineering 82
Countries citing papers authored by Yan Zong
This map shows the geographic impact of Yan Zong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Zong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Zong more than expected).
Fields of papers citing papers by Yan Zong
This network shows the impact of papers produced by Yan Zong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Zong. The network helps show where Yan Zong may publish in the future.
Co-authorship network of co-authors of Yan Zong
This figure shows the co-authorship network connecting the top 25 collaborators of Yan Zong. A scholar is included among the top collaborators of Yan Zong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Zong. Yan Zong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 3 | |
| 5 | 2 | |
| 6 | 3 | |
| 7 | Lipid Nanoparticle (LNP) Enables mRNA Delivery for Cancer Therapybreakdown → | 266 |
| 8 | 3 | |
| 9 | 2 | |
| 10 | 3 | |
| 11 | 7 | |
| 12 | 24 | |
| 13 | 13 | |
| 14 | 17 | |
| 15 | 50 | |
| 16 | 25 | |
| 17 | Resveratrol inhibits lipopolysaccharide-induced activation of osteoclast precursor Raw 264.7 cells | 1 |
| 18 | 2 | |
| 19 | 10 | |
| 20 | 39 |
About Yan Zong
Yan Zong is a scholar working on Cancer Research, Clinical Biochemistry and Behavioral Neuroscience, having authored 30 papers that have together received 532 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (4 papers), Cancer-related molecular mechanisms research (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Cancer Research (83 citations), Immunology (111 citations) and Molecular Biology (353 citations). Yan Zong has collaborated with scholars based in China, United States and India. Frequent co-authors include Tuo Wei, Qiang Cheng, Yi Lin, Qianwen Li, Xiaohua Jie, Xiaoshu Zhou, Jiaxin Hong, Xiaofeng Zhao, Rui Meng and Zhenyu Li. Their work appears in journals such as Advanced Materials, Nature Materials and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.